I13.2

Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC226

Heart Failure, Except End-Stage and Acute

HCC326

Chronic Kidney Disease, Stage 5

CMS-HCC ESRD V24

HCC85

Congestive Heart Failure

HCC136

Chronic Kidney Disease, Stage 5

RxHCC V08

RXHCC186

Heart Failure

RXHCC262

Chronic Kidney Disease Stage 5

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · I13.2
Use additional

code to identify type of heart failure (I50.-) code to identify the stage of chronic kidney disease (N18.5, N18.6)

Inherited from I13Hypertensive heart and chronic kidney disease
Includes

any condition in I11.- with any condition in I12.- cardiorenal disease cardiovascular renal disease

Inherited from I10-I1AHypertensive diseases
Excludes 1

neonatal hypertension (P29.2) primary pulmonary hypertension (I27.0)

Excludes 2

hypertensive disease complicating pregnancy, childbirth and the puerperium (O10-O11, O13-O16)

Use additional

code to identify: exposure to environmental tobacco smoke (Z77.22) history of tobacco dependence (Z87.891) occupational exposure to environmental tobacco smoke (Z57.31) tobacco dependence (F17.-) tobacco use (Z72.0)

Inherited from chapter 9Diseases of the circulatory system
Excludes 2

certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) systemic connective tissue disorders (M30-M36) transient cerebral ischemic attacks and related syndromes (G45.-)

Official Guidelines for I13.2

FY 2026 ›